Yangxian Xu

753 total citations
15 papers, 365 citations indexed

About

Yangxian Xu is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Yangxian Xu has authored 15 papers receiving a total of 365 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 8 papers in Cancer Research and 3 papers in Oncology. Recurrent topics in Yangxian Xu's work include Cancer-related molecular mechanisms research (6 papers), Circular RNAs in diseases (4 papers) and MicroRNA in disease regulation (4 papers). Yangxian Xu is often cited by papers focused on Cancer-related molecular mechanisms research (6 papers), Circular RNAs in diseases (4 papers) and MicroRNA in disease regulation (4 papers). Yangxian Xu collaborates with scholars based in China, United States and Canada. Yangxian Xu's co-authors include Guang Ji, Hanchen Xu, Wenjun Zhou, Yujing Liu, Yang Liu, Chunyan Wang, Yanqi Dang, Haiyan Song, Mingzhe Zhu and Aiguang Zhao and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Journal of Ethnopharmacology.

In The Last Decade

Yangxian Xu

15 papers receiving 364 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yangxian Xu China 9 295 199 44 31 30 15 365
Zeng Chang-qian China 8 237 0.8× 210 1.1× 38 0.9× 22 0.7× 20 0.7× 12 341
Fang Cao China 13 234 0.8× 110 0.6× 49 1.1× 29 0.9× 26 0.9× 21 357
Yuzhu Zhang China 10 218 0.7× 181 0.9× 47 1.1× 15 0.5× 40 1.3× 20 329
Siwei Liu China 10 275 0.9× 211 1.1× 24 0.5× 19 0.6× 31 1.0× 13 406
Weiqian Li China 9 190 0.6× 118 0.6× 52 1.2× 20 0.6× 27 0.9× 19 294
Yue X China 9 256 0.9× 225 1.1× 50 1.1× 14 0.5× 28 0.9× 19 377
Kam-Fai Lee Taiwan 9 187 0.6× 105 0.5× 81 1.8× 39 1.3× 29 1.0× 9 392
Zeqiang Ren China 12 322 1.1× 219 1.1× 92 2.1× 22 0.7× 41 1.4× 19 441

Countries citing papers authored by Yangxian Xu

Since Specialization
Citations

This map shows the geographic impact of Yangxian Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yangxian Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yangxian Xu more than expected).

Fields of papers citing papers by Yangxian Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yangxian Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yangxian Xu. The network helps show where Yangxian Xu may publish in the future.

Co-authorship network of co-authors of Yangxian Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Yangxian Xu. A scholar is included among the top collaborators of Yangxian Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yangxian Xu. Yangxian Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Liu, Yujing, et al.. (2025). Huang-qin decoction alleviates deoxycholic acid-induced colorectal cancer in mice by regulating gut microbiota. Journal of Ethnopharmacology. 346. 119715–119715. 3 indexed citations
2.
Su, Yu‐Wen, Lu Lu, Zhi Jiang, et al.. (2025). Sijunzi decoction granules for the treatment of advanced refractory colorectal cancer: study protocol for a multicenter, randomized, double-blind, placebo-controlled trial. Frontiers in Medicine. 12. 1523913–1523913. 1 indexed citations
3.
Lu, Lu, Mingjie Chen, Guicheng Zhang, et al.. (2024). Comprehensive profiling of extrachromosomal circular DNAs in colorectal cancer progression. Scientific Reports. 14(1). 28519–28519. 1 indexed citations
4.
Dang, Yanqi, et al.. (2023). tRNA‐derived fragments are promising biomarkers for screening of early colorectal cancer. SHILAP Revista de lepidopterología. 4(3). e227–e227. 4 indexed citations
5.
6.
Liu, Feng, Liang Dai, Mingzhe Zhu, et al.. (2022). METTL3 promotes colorectal carcinoma progression by regulating the m6A–CRB3–Hippo axis. Journal of Experimental & Clinical Cancer Research. 41(1). 19–19. 72 indexed citations
7.
Lu, Lu, Yujing Liu, Guangtao Zhang, et al.. (2022). The circRNA expression profile of colorectal inflammatory cancer transformation revealed potential predictive biomarkers. Aging. 14(22). 9280–9299. 3 indexed citations
8.
Dai, Liang, Yang Liu, Guang Ji, & Yangxian Xu. (2021). Acupuncture and Derived Therapies for Pain in Palliative Cancer Management: Systematic Review and Meta-Analysis Based on Single-Arm and Controlled Trials. Journal of Palliative Medicine. 24(7). 1078–1099. 7 indexed citations
9.
Liu, Yujing, Chunyan Wang, Wenjun Zhou, et al.. (2021). FHL1 Inhibits the Progression of Colorectal Cancer by Regulating the Wnt/β-Catenin Signaling Pathway. Journal of Cancer. 12(17). 5345–5354. 17 indexed citations
10.
Liu, Feng, Yujing Liu, Wenjun Zhou, et al.. (2021). CircRNA_0084927 promotes colorectal cancer progression by regulating miRNA-20b-3p/glutathione S-transferase mu 5 axis. World Journal of Gastroenterology. 27(36). 6064–6078. 16 indexed citations
11.
Xu, Hanchen, Yujing Liu, Chunyan Wang, et al.. (2020). CircRNA_0000392 promotes colorectal cancer progression through the miR-193a-5p/PIK3R3/AKT axis. Journal of Experimental & Clinical Cancer Research. 39(1). 283–283. 103 indexed citations
12.
Zhu, Mingzhe, Yanqi Dang, Zhenhua Yang, et al.. (2020). Comprehensive RNA Sequencing in Adenoma-Cancer Transition Identified Predictive Biomarkers and Therapeutic Targets of Human CRC. Molecular Therapy — Nucleic Acids. 20. 25–33. 28 indexed citations
13.
Dang, Yanqi, Dan Hu, Chunlin Li, et al.. (2020). Comprehensive analysis of 5‐hydroxymethylcytosine in zw10 kinetochore protein as a promising biomarker for screening and diagnosis of early colorectal cancer. SHILAP Revista de lepidopterología. 10(3). e125–e125. 14 indexed citations
14.
Xu, Yangxian, et al.. (2017). Extracts of Zuo Jin Wan, a traditional Chinese medicine, phenocopies 5-HTR1D antagonist in attenuating Wnt/β-catenin signaling in colorectal cancer cells. BMC Complementary and Alternative Medicine. 17(1). 506–506. 36 indexed citations
15.
Sui, Hua, Hanchen Xu, Qing Ji, et al.. (2015). 5-hydroxytryptamine receptor (5-HT1DR) promotes colorectal cancer metastasis by regulating Axin1/β-catenin/MMP-7 signaling pathway. Oncotarget. 6(28). 25975–25987. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zeng Chang-qian Breakdown of academic impact, for papers by Fang Cao Breakdown of academic impact, for papers by Yuzhu Zhang Breakdown of academic impact, for papers by Siwei Liu Breakdown of academic impact, for papers by Weiqian Li Breakdown of academic impact, for papers by Yue X Breakdown of academic impact, for papers by Kam-Fai Lee Breakdown of academic impact, for papers by Zeqiang Ren
Rankless by CCL
2026